We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Technology Networks Antibodies and Screening Webinar 25th July 2024

Recent Advances in Screening Technologies for Human Monoclonal Antibodies for Infectious Diseases

Human monoclonal antibodies are increasingly being used to prevent or treat infectious diseases. The list of key features needed to identify promising leads that can be developed as biological drugs is evolving rapidly. 


In this webinar, Dr. James E. Crowe from Vanderbilt University Medical Center will discuss current approaches to screening for high potency, broad reactivity, synergistic combinations and reduced escapability.


Attendees will gain insights into:

  • Cutting-edge screening strategies for pinpointing high potency antibodies
  • Exploring the landscape of broadly reactive antibodies through current methodologies
  • Unraveling the potential of synergistic combinations of antiviral antibodies
  • Navigating the challenge of reducing escapability in neutralizing antibodies
Speaker
A picture of Dr. James E. Crowe
Dr. James E. Crowe
Director of the Vanderbilt Vaccine Center
Vanderbilt University Medical Center
Sponsored by

Interested in sponsoring this webinar? Contact our friendly sales team here.
Register for FREE Now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
Want to invite a colleague?

Click the button below to begin inviting a colleague to this Webinar